Halozyme's Upcoming Conferences: Investors Take Note!
Halozyme's Upcoming Investor Conferences
Halozyme Therapeutics, Inc. (NASDAQ: HALO) is gearing up to participate in several significant investor conferences that aim to foster discussions and networking opportunities within the financial community. Dr. Helen Torley, the company’s president and CEO, will lead these initiatives, offering investors insights into Halozyme's innovative programs and future direction.
Conference Details Overview
The firm has confirmed its attendance at multiple events, which are strategically designed to showcase Halozyme's advancements in biopharmaceuticals:
Benchmark 2025 Healthcare House Call Virtual Conference
This engaging virtual platform will feature one-on-one meetings, enabling investors to have personal interactions with Dr. Torley and other key executives.
Goldman Sachs 46th Annual Global Healthcare Conference 2025
In addition to individual meetings, Halozyme will conduct a fireside chat, providing an intimate setting for discussions regarding their strategic direction and innovations in drug delivery technologies.
Webcast Availability
A live audio webcast of Halozyme’s presentations will be accessible via the Investor Relations section of their official website. Following the live presentations, there will be replays available for 90 days, ensuring that interested parties can stay informed even if they miss the live event.
About Halozyme
Halozyme is at the forefront of biopharmaceutical innovation, dedicated to transforming patient experiences and treatment outcomes. They have developed the ENHANZE technology, an advanced method that facilitates the subcutaneous delivery of drugs, striving to make treatments easier for patients. ENHANZE has already benefited one million patients and is integrated into ten commercial products across more than 100 global markets.
The company has successfully partnered with renowned pharmaceutical firms such as Pfizer, Roche, and Takeda, enabling broader use of its groundbreaking drug delivery systems. Halozyme’s commercial products, Hylenex and XYOSTED, highlight their commitment to enhancing patient care through technology.
With operations in locations such as San Diego, CA; Ewing, NJ; and Minnetonka, MN, Halozyme is expanding its reach and continuing to innovate within the biopharmaceutical space.
Company Contacts
For those seeking more information or having inquiries related to investor relations, Tram Bui, VP, Investor Relations, can be reached at 609-359-3016. For public relations queries, Samantha Gaspar from Teneo is available at 212-886-9356.
Frequently Asked Questions
What is Halozyme's role in the biopharmaceutical industry?
Halozyme is a leading biopharmaceutical company known for developing innovative drug delivery technologies, enhancing patient care.
Who is attending the upcoming investor conferences?
Dr. Helen Torley, CEO of Halozyme, will represent the company at the conferences, engaging with investors directly.
How can investors access the conference presentations?
Live webcasts of the presentations will be available on Halozyme's Investor Relations website, along with replays for later viewing.
What are some of Halozyme's key technologies?
Halozyme’s ENHANZE technology is a significant innovation aiding subcutaneous drug delivery, leading to better patient experiences and outcomes.
Where is the headquarters of Halozyme located?
Halozyme is headquartered in San Diego, California, with additional offices in Ewing, NJ, and Minnetonka, MN.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
